Prognostic value of preoperative lymphocyte-to-C- reactive protein ratio and albumin to alkaline phosphatase ratio in patients with osteosarcoma
暂无分享,去创建一个
[1] Xuefeng Liu,et al. Association Between the Pretreatment Albumin-to-Alkaline Phosphatase Ratio and Clinical Outcomes in Patients With Bladder Cancer Treated With Radical Cystectomy: A Retrospective Cohort Study , 2021, Frontiers in Oncology.
[2] Yingze Zhang,et al. Prognostic Value of the Preoperative Lymphocyte-to-C-Reactive Protein Ratio and Albumin-to-Globulin Ratio in Patients with Osteosarcoma , 2020, OncoTargets and therapy.
[3] P. Auvinen,et al. The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype , 2020, Breast Cancer Research and Treatment.
[4] M. Schell,et al. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma , 2020, BMC Cancer.
[5] D. McMillan,et al. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer. , 2020, Annals of surgery.
[6] D. McMillan,et al. Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer. , 2019, Annals of surgery.
[7] Yue Yang,et al. Pretreatment albumin-to-alkaline phosphatase ratio as a prognostic indicator in solid Cancers: A meta-Analysis with trial sequential analysis. , 2020, International journal of surgery.
[8] Wei Wei,et al. Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study , 2020, Liver international : official journal of the International Association for the Study of the Liver.
[9] F. Tan,et al. Preoperative systemic immune-inflammation index and prognostic nutritional index predict prognosis of patients with pulmonary neuroendocrine tumors after surgical resection , 2020, Annals of translational medicine.
[10] Hongyuan Xing,et al. The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] D. McMillan,et al. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer. , 2020, Clinical nutrition.
[12] Y. Toiyama,et al. Prognostic Potential of Lymphocyte–C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy , 2020, Journal of Gastrointestinal Surgery.
[13] Xiaojing Zhang,et al. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma , 2020, World Journal of Surgical Oncology.
[14] Peng Yang,et al. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis. , 2019, International journal of surgery.
[15] K. Oba,et al. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer , 2019, Annals of Surgical Oncology.
[16] Z. Shao,et al. Prognostic value of prognostic nutritional index and systemic immune‐inflammation index in patients with osteosarcoma , 2019, Journal of cellular physiology.
[17] D. Lin,et al. Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients. , 2019, Neoplasma.
[18] S. Natsugoe,et al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer , 2019, BMC cancer.
[19] S. Ikeda,et al. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status , 2017, BMC Cancer.
[20] C. Tu,et al. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma , 2017, OncoTargets and therapy.
[21] B. Carr,et al. Serum Albumin Levels in Relation to Tumor Parameters in Hepatocellular Carcinoma Patients , 2017, The International journal of biological markers.
[22] Wenchuan Wu,et al. Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection , 2017, Journal of Cancer.
[23] Bethany Rader. Alkaline Phosphatase, an Unconventional Immune Protein , 2017, Front. Immunol..
[24] Dongxi Xiang,et al. Prognostic value of inflammation-based scores in patients with osteosarcoma , 2016, Scientific Reports.
[25] Tao Liu,et al. Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma , 2015, FEBS open bio.
[26] E. Scarpi,et al. Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. , 2012, Clinical breast cancer.
[27] Yun-Shien Lee,et al. Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence? , 2011, Journal of Gastrointestinal Surgery.
[28] Alberto Mantovani,et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.
[29] D. Santini,et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.
[30] M. Brennan,et al. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer , 2006, Cancer.
[31] N. Ilhan,et al. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. , 2004, World journal of gastroenterology.
[32] C. McArdle,et al. Albumin Concentrations Are Primarily Determined by the Body Cell Mass and the Systemic Inflammatory Response in Cancer Patients With Weight Loss , 2001, Nutrition and cancer.
[33] Progress report Alkaline phosphatase , 2006 .